NCT01462565 - Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 1, 2011

Primary Completion Date

May 16, 2012

Study Completion Date

November 8, 2012

Conditions

Hypertension, Pulmonary

Interventions

DRUG

current marketed FLOLAN (epoprostenol sodium)

continuous intravenous infusion

DRUG

new thermo stable formulation of epoprostenol sodium

continuous intravenous infusion

Trial Locations (8)

GSK Investigational Site, Baltimore

GSK Investigational Site, Miami Beach

GSK Investigational Site, Columbus

GSK Investigational Site, Chicago

GSK Investigational Site, Boston

GSK Investigational Site, Dallas

GSK Investigational Site, Québec

GSK Investigational Site, Amsterdam